Some people may notice early changes, while for others, weight loss may be more gradual
Nat Commun 15:4548 Wharton S, Calanna S, Davies M et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between Gastrointestinal adverse events and weight loss
doi: 10.1111/dom.70382 Retrieved from Usach, I., Martinez, R., Festini, T., & Peris, J
After four (20 days), 6.25%
Its likely due to a combination of factors, including the medication itself and how your body specifically, your immune system responds to it
[3] Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use tirzepatide, and any symptoms such as neck mass, hoarseness, difficulty swallowing, or shortness of breath should be reported immediately